Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103529962 | 10352996 | 2 | F | 201305 | 20150810 | 20140730 | 20160726 | PER | US-ABBVIE-14P-163-1216552-00 | ABBVIE | 53.72 | YR | F | Y | 49.94000 | KG | 20160726 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103529962 | 10352996 | 1 | PS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNKNOWN | 21402 | 100 | UG | QD | |||||||
103529962 | 10352996 | 2 | SS | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | Unknown | U | LD1 02 | 0 | |||||||||
103529962 | 10352996 | 3 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Unknown | 6,000 UNITS | 0 | CAPSULE | QD | ||||||||
103529962 | 10352996 | 4 | C | RABEPRAZOLE SOD DR | 2 | Unknown | 0 | 20 | MG | TABLET | |||||||||
103529962 | 10352996 | 5 | C | MULTIVITAMINS | VITAMINS | 1 | Unknown | 0 | 500 | UG | CAPSULE | ||||||||
103529962 | 10352996 | 6 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | 0 | |||||||||||
103529962 | 10352996 | 7 | C | ALIVE WOMEN'S 50 PLUS GUMMY VITAMINS | 2 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
103529962 | 10352996 | 1 | Thyroid disorder |
103529962 | 10352996 | 2 | Autoimmune thyroiditis |
103529962 | 10352996 | 3 | Product used for unknown indication |
103529962 | 10352996 | 4 | Product used for unknown indication |
103529962 | 10352996 | 5 | Product used for unknown indication |
103529962 | 10352996 | 6 | Product used for unknown indication |
103529962 | 10352996 | 7 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
103529962 | 10352996 | Aphasia | |
103529962 | 10352996 | Drug intolerance | |
103529962 | 10352996 | Lactose intolerance | |
103529962 | 10352996 | Lymphadenectomy | |
103529962 | 10352996 | Lymphoma | |
103529962 | 10352996 | Malabsorption | |
103529962 | 10352996 | Malaise | |
103529962 | 10352996 | Thyroid cancer | |
103529962 | 10352996 | Thyroidectomy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
103529962 | 10352996 | 1 | 201303 | 0 |